CV Health Plus Genomics™

This profile analyzes blood and utilizes NMR fractionation technology for state-of-the-art lipid markers and independent risk factors that illuminate the clinical complexity of cardiovascular disease (CVD) as well as a patient's genomic predisposition to cardiovascular diseases. Together, these markers provide a thorough assessment of cardiovascular health status, revealing the biochemical environment and cardiogenomic risk associated with inflammation, lipid deposits, endothelial dysfunction, and clotting factors underlying cardiovascular disease.

Analyte List
ApoE
Cholesterol
Factor II
Factor V
Fibrinogen
HDL
HDL-P
HDL-Size
HDLL-P
Homocysteine
LDL
LDL-P
LDL-Size
LDLS-P
Lp(a)
Lp-PLA2
MTHFR
Triglycerides
VLDL-P
VLDL-Size
hs C-Reactive Protein
Specimen Requirements
1 x 4 ml serum, 3 ml plasma, 5 ml Z-serum separator, and 3 ml whole blood, fasting